LIPID HANDLING CONVEYS SENSITIVITY TO ANTI-BCMA IMMUNOTHERAPY IN MULTIPLE MYELOMA

被引：0
|
作者：
La Spina, E. [1 ]
Romano, A. [3 ]
Giallongo, C. [2 ]
Tibullo, D. [1 ]
Dulcamare, I.
Scuderi, E. [1 ]
Scandura, G. [3 ]
Cambria, D. [3 ]
Cortellino, S. [5 ]
Mecca, M. [5 ]
Picerno, S. [5 ]
Neri, A.
Amoresano, A. [4 ]
Pinto, G. [4 ]
Serpico, S. [4 ]
Sgambato, A.
Palumbo, G. A. [2 ]
Di Raimondo, F. [3 ]
机构：
[1] Univ Catania, Dept Biotechnol & Biomed Sci, Catania, Italy
[2] Univ Catania, Dept Med Surg Sci & Adv Technol GF Ingrassia, Catania, Italy
[3] Univ Catania, Dept Surg & Med Specialties, Catania, Italy
[4] Univ Naples Federico II, Dept Chem Sci, Naples, Italy
[5] IRCCS, Referral Canc Ctr Basilicata, Lab Preclin & Translat Res, CROB, San Giovanni Rotondo, Italy
来源：
HAEMATOLOGICA | 2024年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P094
引用
收藏
页码：105 / 106
页数：2
相关论文
共 50 条
  • [1] Lipid Handling Induces Ferroptosis and Conveys Sensitivity to Anti-BCMA Immunotherapy in Multiple Myeloma
    La Spina, Enrico
    Cortellino, Salvatore
    Giallongo, Cesarina
    Mecca, Marisabel
    Picerno, Simona
    Amoresano, Angela
    Pinto, Gabriella
    Serpico, Stefania
    Sgambato, Alessandro
    Scandura, Grazia
    Cambria, Daniela
    Tibullo, Daniele
    Neri, Antonino
    Di Raimondo, Francesco
    Romano, Alessandra
    BLOOD, 2023, 142
  • [2] Anti-BCMA novel therapies for multiple myeloma
    Sammartano, Vincenzo
    Franceschini, Marta
    Fredducci, Sara
    Caroni, Federico
    Ciofini, Sara
    Pacelli, Paola
    Bocchia, Monica
    Gozzetti, Alessandro
    CANCER DRUG RESISTANCE, 2023, 6 (01) : 169 - 181
  • [3] Effective anti-BCMA retreatment in multiple myeloma
    Gazeau, Nicolas
    Beauvais, David
    Yakoub-Agha, Ibrahim
    Mitra, Suman
    Campbell, Timothy B.
    Facon, Thierry
    Manier, Salomon
    BLOOD ADVANCES, 2021, 5 (15) : 3016 - 3020
  • [4] Overview of anti-BCMA CAR-T immunotherapy for multiple myeloma and relapsed/refractory multiple myeloma
    Feng, Deming
    Sun, Jian
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (02)
  • [5] The Impact of Soluble BCMA and BCMA Gain on Anti-BCMA Immunotherapies in Multiple Myeloma
    Lee, Holly
    Durante, Michael
    Ahn, Sungwoo
    Leblay, Noemie
    Poorebrahim, Mansour
    Maity, Ranjan
    Tilmont, Remi
    Barakat, Elie
    Jung, David
    Ziccheddu, Bachisio
    Brake, Alexis
    Landgren, Ola
    Diamond, Benjamin
    Maura, Francesco
    Neri, Paola
    Bahlis, Nizar J.
    BLOOD, 2023, 142
  • [6] Exploring lipid metabolic dynamics in multiple myeloma: implications for anti-BCMA immunotherapy resistance and ferroptotic cell death
    La Spina, E.
    Romano, A.
    Scandura, G.
    Giallongo, C.
    Cortellino, S.
    Longhitano, L.
    Giallongo, S.
    Zuppelli, T.
    Palumbo, G. A.
    Di Raimondo, F.
    Volti, G. Li
    Tibullo, D.
    FEBS OPEN BIO, 2024, 14 : 333 - 334
  • [7] A novel anti-BCMA lipid-based nanoparticle for multiple myeloma therapy
    Al-Ahmady, Zahraa
    Asifuddin, Syed
    Al-Kaisi, Firas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S88 - S89
  • [8] Anti-BCMA CAR-T cell immunotherapy for relapsed or refractory multiple myeloma
    Zhang, Xiaohui
    Ouyang, Chenxi
    Sun, Guofeng
    Liu, Hongfeng
    Qi, Junyuan
    Suo, Xiaohui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (04)
  • [9] Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma
    Dalla Palma, Benedetta
    Marchica, Valentina
    Catarozzo, Maria Teresa
    Giuliani, Nicola
    Accardi, Fabrizio
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 11
  • [10] Anti-BCMA antibodies in the future management of multiple myeloma
    Gavriatopoulou, Maria
    Ntanasis-Stathopoulos, Ioannis
    Dimopoulos, Meletios Athanasios
    Terpos, Evangelos
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (04) : 319 - 326
12345